These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3775769)

  • 1. Coronary dilator effect of MCI-176, a new calcium channel blocker, in dogs.
    Horii D; Ishibashi A
    Tohoku J Exp Med; 1986 Sep; 150(1):101-2. PubMed ID: 3775769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of MCI-176, a new calcium channel blocker, on large and small coronary arteries in dogs.
    Ishibashi T; Nakazawa M; Imai S
    Cardiovasc Res; 1989 Apr; 23(4):295-302. PubMed ID: 2590912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collateral blood flow following acute coronary artery occlusion: comparison of a new intracellular calcium antagonist (KT-362) and diltiazem.
    Farber NE; Gross GJ
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):66-72. PubMed ID: 2475718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans.
    Bourassa MG; Cote P; Theroux P; Tubau JF; Genain C; Waters DD
    Chest; 1980 Jul; 78(1 Suppl):224-30. PubMed ID: 7398410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog.
    Nichols AJ; Koster PF; Ohlstein EH
    Br J Pharmacol; 1990 Mar; 99(3):597-601. PubMed ID: 2184913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of MCI-176, a new quinazolinone calcium antagonist, on myocardial energy and carbohydrate metabolism in ischemic dog hearts.
    Abe Y; Ichihara K; Abiko Y
    Biochem Pharmacol; 1991 Feb; 41(3):445-51. PubMed ID: 1825270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MCI-176, a new calcium antagonist, on the calcium induced contraction of isolated porcine coronary arteries.
    Ishibashi A; Horii D
    Jpn J Pharmacol; 1987 Feb; 43(2):234-6. PubMed ID: 3573428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin on cardiohemodynamics in anesthetized dogs.
    Chang TH; Adachi H; Okuyama T; Mori N; Saito I; Zhang KY; Sun XD; Li JM
    Zhongguo Yao Li Xue Bao; 1994 Nov; 15(6):507-10. PubMed ID: 7709748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary hemodynamics following intravenous or intracoronary injection of diltiazem in man.
    Bertrand ME; Dupuis BA; Lablanche JM; Tilmant PY; Thieuleux FA
    J Cardiovasc Pharmacol; 1982; 4(5):695-9. PubMed ID: 6182397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
    Quartaroli M; Gambini F; Tarter G; Micheli D; Trist DG; Gaviraghi G
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):326-36. PubMed ID: 1720831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary vasodilator versus cardiac effects of MCI-176, a novel quinazolinone calcium antagonist, in the dog heart.
    Hosono M; Taira N
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):633-40. PubMed ID: 2442528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of diltiazem on coronary flow reserve in humans.
    Rossen JD; Simonetti I; Marcus ML; Braun P; Winniford MD
    Circulation; 1989 Nov; 80(5):1240-6. PubMed ID: 2805261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diltiazem on experimental coronary artery thrombosis in dogs.
    Schumacher WA; Lucchesi BR
    Pharmacology; 1990; 41(1):16-23. PubMed ID: 2236203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
    Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous diltiazem on cardiocirculatory dynamics and cardiac output distribution in conscious spontaneously hypertensive rats.
    Flaim SF; Newman ED; Annibali JA
    J Cardiovasc Pharmacol; 1986; 8(2):241-51. PubMed ID: 2422460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
    Hara Y; Ichihara K; Abiko Y
    J Pharmacol Exp Ther; 1988 Apr; 245(1):305-10. PubMed ID: 3361449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage- and use-dependent block of the inward calcium current by MCI-176, a new non-dihydropyridine calcium antagonist, in canine ventricular muscles and single ventricular cells of the guinea-pig.
    Iijima T; Takahashi K; Taira N
    Jpn J Pharmacol; 1988 Feb; 46(2):155-64. PubMed ID: 2454341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.